Patient demographics
| Patient . | Category . | M/F . | Age, y . | Duration of disease, y . | Tryptase, ng/mL . | sCD117, AU/mL . | Bone marrow . |
|---|---|---|---|---|---|---|---|
| 1 | ISM | F | 39 | 13 | 26 | 480 | NC, focal |
| 2 | ISM | F | 49 | 9 | 139 | 753 | NC, focal |
| 3 | SSM | M | 45 | 30 | 164 | 1865 | HC, diffuse |
| 4 | SSM | M | 71 | 33 | 217 | 4755 | HC, focal |
| 5 | SSM | M | 67 | 9 | 262 | ND | HC, focal |
| Patient . | Category . | M/F . | Age, y . | Duration of disease, y . | Tryptase, ng/mL . | sCD117, AU/mL . | Bone marrow . |
|---|---|---|---|---|---|---|---|
| 1 | ISM | F | 39 | 13 | 26 | 480 | NC, focal |
| 2 | ISM | F | 49 | 9 | 139 | 753 | NC, focal |
| 3 | SSM | M | 45 | 30 | 164 | 1865 | HC, diffuse |
| 4 | SSM | M | 71 | 33 | 217 | 4755 | HC, focal |
| 5 | SSM | M | 67 | 9 | 262 | ND | HC, focal |
M indicates male; F, female; sCD117, soluble CD117 (soluble Kit); AU, arbitrary units; ISM, indolent systemic mastocytosis; NC, normocellular; SSM, smoldering systemic mastocytosis; HC, hypercellular; and ND, not determined.